1.901 - 1.925 of 34.211
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 465,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,44x
- Analysis
- Novo Nordisk Call 395,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,38x
- Analysis
- Novo Nordisk Call 355,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,10x
- Analysis
- Novo Nordisk Call 455,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,29x
- Analysis
- Novo Nordisk Call 325,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,31x
- Analysis
- Novo Nordisk Call 325,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,90x
- Analysis
- Novo Nordisk Call 475,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,91x
- Analysis
- Novo Nordisk Call 365,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,69x
- Analysis
- Novo Nordisk Call 375,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,82x
- Analysis
- Novo Nordisk Call 355,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,63x
- Analysis
- Novo Nordisk Call 435,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,95x
- Analysis
- Novo Nordisk Call 425,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,65x
- Analysis
- Novo Nordisk Call 445,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,35x
- Analysis
- Novo Nordisk Call 495,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,03x
- Analysis
- Novo Nordisk Call 345,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,01x
- Analysis
- Novo Nordisk Call 335,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,42x
- Analysis
- Novo Nordisk Call 395,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,04x
- Analysis
- Novo Nordisk Call 405,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,13x
- Analysis
- Novo Nordisk Call 435,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,39x
- Analysis
- Novo Nordisk Call 285,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,86x
- Analysis
- Novo Nordisk Call 265,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,62x
- Analysis
- Novo Nordisk Call 405,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,46x
- Analysis
- Novo Nordisk Call 275,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,74x
- Analysis
- Novo Nordisk Call 535,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,18x
- Analysis
- Novo Nordisk Call 375,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,12x
- Analysis